Menu

28th Annual
San Diego Heart Failure Symposium

Advances in the Recognition & Treatment of Heart Failure
Hilton La Jolla Torrey Pines, La Jolla, California
July 8 & 9, 2022

PROGRAM - Subject to Change
Friday, July 8, 2022
Pacific Time

7:45-8:15am

Registration Open

8:15-9:15

PRODUCT THEATRE I - Non-CME
Breakfast Session
Management of CKD and Hyperkalemia
Souhiela Fawaz, BS Pharm, PhD
Warren Fegenbush, PharmD, BCPS
Supported by: AstraZeneca

9:30am

Introduction to the 28th Annual Symposium: Heart Failure in 2022
Barry Greenberg, MD

SESSION I - Update on Risk Factors and Prevention
Michael Wilkinson, MD (Moderator)

9:40-9:55

FEATURED LECTURE I
Exercise for CV Disease Prevention

Michael Wilkinson, MD

9:55-10:10

Complementary and Alternative Medicines for Treating CV Disease
Sheryl Chow, Pharm D

10:10-10:25

Strategies for Managing Hypertension to Prevent CV and Renal Disease
Christian Mende, MD

10:25-10:40

New Therapies for Hyperlipidemia
Michael Wilkinson, MD

10:40-10:55

Treating Diabetes to Prevent CV Disease
Jia Shen, MD

10:55-11:20

Panel Discussion / Audience Q & A
Reducing Risk of CV and CK Disease

Jia Shen, MD (Moderator)
Drs. Mende, Wilkinson, Chow and Alexandra Salcedo, RDN, CDCES (Panelists)

11:20-11:40

FEATURED LECTURE II
Pulmonary Arterial Hypertension: Diagnosis and Management

Nick Kim, MD

11:50-12:50

PRODUCT THEATRE II - Non-CME
Lunch Session
Redefining the Treatment Landscape of Symptomatic NYHA Class II-III Obstructive HCM With CAMZYOS™, the First and Only FDA-Approved Cardiac Myosin Inhibitor
Florian Rader, MD    Bio
Supported by: Bristol Meyers Squibb

1:00-1:15

Visit Exhibit Hall

Session II - HFpEF, Amyloid and Hypertrophic Cardiomyopathy
Marcus Anthony (Tony) Urey, MD (Moderator)

1:15-1:35

FEATURED LECTURE III
Recognizing and Treating Amyloid

Marcus Anthony (Tony) Urey, MD

1:35-1:55

Emerging Concepts of Understanding and Treating HFpEF
Barry Greenberg, MD

1:55-2:15

Managing Patients with Hypertrophic Cardiomyopathy (HCM) in 2022
Jorge Silva Enciso, MD

2:15-2:35

Genetic Testing for Diseases Causing Cardiomyopathy
Kimberly Hong, MD

2:35-2:55

Case Presentation / Audience Q & A
Marcus Anthony (Tony) Urey, MD (Presenter)
Drs. Greenberg, Silva Enciso and Hong (Panelists)

2:55-3:15

Coffee Break/Visit Exhibit Hall

Session III - Managing Atrial Fibrillation and Prevention of Sudden Death
Ulrika Birgersdotter-Green, MD (Moderator)

3:15-3:30

Stroke Prevention in Patients with Atrial Fibrillation; Drugs and Devices
Jonathan Hsu, MD

3:30-3:45

Predictors of Sudden Cardiac Death
Gordon Ho, MD

3:45-4:00

Wearable Devices for Detecting and Treating Arrhythmias
David Krummen, MD

4:00-4:15

ICDs for Preventing Sudden Cardiac Death
Ulrika Birgersdotter Green, MD

4:15-4:35

Case Presentation / Audience Q & A
Ulrika Birgersdotter-Green, MD (Moderator)
Drs. Hsu, Ho and Krummen (Panelists)

4:35

Adjourn Day 1


Saturday, July 9

6:40am

Registration Opens

7:00-8:00

PRODUCT THEATRE III - Non-CME
Breakfast Session
Treatment considerations for patients with HFrEF and select updates from the 2022 HF Guideline
Warren Wexelman, MD
supported by: Merck

8:00-8:15

Visit Exhibit Hall

8:15

Welcome to Day 2 / Highlights of Day 1
Barry Greenberg, MD

Session IV - Prevention of CV Events and Assessing Patients with Heart Failure
Barry Greenberg, MD (Moderator)

8:20-8:35

DOACs to Prevent CV Disease
Dan Blanchard, MD

8:35-8:50

Devices for Detecting and Preventing Worsening HF
Hao (Howie Tran), MD

8:50-9:05

Assessing Kidney Function in Patients with Heart Failure:
Implications for Patient Management
Nick Wettersten, MD

9:05-9:20

Biomarkers to Assess Presence of HF, Risk of Events and Response to Treatment
Lori Daniels, MD

9:20-9:40

FEATURED LECTURE IV
Acute and Long Term Effects of COVID on the Heart

Pam Taub, MD

9:40-10:00

Panel Discussion / Audience Q/A
Barry Greenberg, MD (Moderator)
Drs. Tran, Wettersten, Daniels, Blanchard and Taub (Panelists)

10:00-10:20

Coffee Break / Visit Exhibit Hall

10:20-11:20

PRODUCT THEATRE IV - Non-CME
Improved Management Strategies for Patients with Heart Failure and Coronary Artery Disease - The Who, How and Why
Sponsored by Abiomed
10:20
Introduction: Defining the Problem
     Barry Greenberg, MD
10:25-10:40
Recognizing CAD in Heart Failure Patients - The Who
     Nancy Albert, RN, PhD
10:40-10:55
Revascularization Impact on HF Symptoms with Reduced EF: Insights from Restore-EF & Protect III - The How
     Mitul Patel, MD
10:55-11:05
Achieving GDMT for Ischemic Cardiomyopathy
     Gregg Fonarow, MD
11:05-11:20
Ischemic HF and PCI: Emerging Evidence in Patients with Systolic Dysfunction (PROTECT IV) - The Why
     Ehtisham Mahmud, MD

Session V - Meeting the Challenges in Worsening Heart Failure with Reduced Ejection Fraction: Opportunities to Improve Clinical Outcomes
LUNCH SESSION
Supported by an independent educational grant from Cytokinetics Incorporated

11:30

Introduction
Barry Greenberg, MD

11:35-11:55

Worsening Heart Failure in HFrEF: Clinical Course and Challenges in Patient Management
Gregg Fonarow, MD

11:55-12:15

New and Emerging Therapies for WHF in HFrEF: Exploring the Evidence with Vericiguat and Omecamtiv Mecarbil
John Teerlink, MD

12:15-12:35

Case Presentation
Improving Outcomes in Patients with HFrEF and WHF

Kimberly Hong, MD (Presenter)
Gregg Fonarow, MD; John Teerlink, MD; Marcus Anthony (Tony) Urey, MD; Trina Huynh, Pharm D (Panelists)

12:35-12:45

Audience Q & A
Barry Greenberg, MD (Moderator)
Drs. Teerlink, Fonarow, Hong, Urey and Huynh (Panelists)

12:45-1:00

Coffee Break / Visit Exhibit Hall

1:00-1:30

8th Annual Stanley Lloyd, MD Lecture
Recognizing and Correcting Inequities in Health Care
Cheryl Anderson, MD

1:30

Audience Q & A

Session VI - Advanced Therapies
Eric Adler, MD (Moderator)

1:40-1:55

Recognizing Stage D Heart Failure
Kimberly Hong, MD

1:55-2:15

FEATURED LECTURE V
Advances in Cardiac Transplantation: What Can Patients Expect?
Victor Pretorius, MBChB

2:15-2:30

Role of Left Ventricular Assist Devices in Management of Stage D HF
Eric Adler, MD

2:30-2:45

Gene and Cell Therapies - Closer and Closer to Prime Time
Barry Greenberg, MD

2:45-3:00

Panel Discussion
Eric Adler, MD (Moderator)
Drs. Hong, Pretorius, Urey, Greenberg and Holly Anguiano, LCSW (Discussants)

3:00-3:10

Coffee Break / Visit Exhibit Hall

Session VII - Optimizing the Medical Management of Patients with Heart Failure
Barry Greenberg, MD (Moderator)

3:10-3:25

What’s New in ’22 - Insights into the 2022 ACC/AHA/HFSA Guidelines for HF
Clyde Yancy, MD

3:25-3:40

Expanding Indications for ARNIs in Treating Heart Failure
Barry Greenberg, MD

3:40-3:55

SGLT2 Inhibitors for Treating HFrEF, HFpEF and Everything In Between
Gregg Fonarow, MD

3:55-4:10

Other Medications: Role of Ivabradine, Vericiguat, Hyd-ISDN, Digoxin
Clyde Yancy, MD

4:10-4:25

Mineralocorticoid Receptor Antagonists to Prevent CV Disease and Treat HF
Nick Wettersten, MD

4:25-4:45

FEATURED PANEL
Putting It All Together - How To Implement Disease Modifying Therapies
(Case Presentation, Panel Discussion, Audience Q & A)

Barry Greenberg, MD (Moderator)
Drs. Yancy, Fonarow and Wettersten, Trina Huynh Pharm D, Julia McCain, PA (Panelists)

4:45

Adjourn Until the 29th Annual San Diego Heart Failure Symposium